<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">glaucoma</journal-id><journal-title-group><journal-title xml:lang="ru">Национальный журнал Глаукома</journal-title><trans-title-group xml:lang="en"><trans-title>National Journal glaucoma</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2078-4104</issn><issn pub-type="epub">2311-6862</issn><publisher><publisher-name>Federal State Budgetary Institution of Science “Krasnov Research Institute of Eye Diseases”</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.53432/2078-4104-2024-23-4-11-20</article-id><article-id custom-type="elpub" pub-id-type="custom">glaucoma-539</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ СТАТЬИ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ORIGINAL ARTICLES</subject></subj-group></article-categories><title-group><article-title>Морфометрические изменения параметров диска зрительного нерва в условиях офтальмогипертензии, индуцированной интравитреальным введением ингибиторов ангиогенеза</article-title><trans-title-group xml:lang="en"><trans-title>Morphometric changes in optic nerve head parameters in ocular hypertension induced by intravitreal administration of angiogenesis inhibitors</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-8319-926X</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Андреева</surname><given-names>Ю. С.</given-names></name><name name-style="western" xml:lang="en"><surname>Andreeva</surname><given-names>Yu. S.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Андреева Юлия Сергеевна, аспирант отдела патологии сетчатки и зрительного нерва </p><p>119021, Москва, ул. Россолимо, 11А</p></bio><bio xml:lang="en"><p>postgraduate student at the Department of Retinal and Optic Nerve Pathology </p><p>11A Rossolimo St., Moscow, 119021</p></bio><email xlink:type="simple">Juliu95@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-6791-4219</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Алхарки</surname><given-names>Л.</given-names></name><name name-style="western" xml:lang="en"><surname>Alharki</surname><given-names>L.</given-names></name></name-alternatives><bio xml:lang="ru"><p>к.м.н., старший научный сотрудник отдела инновационных витреоретинальных технологий, доцент кафедры офтальмологии</p><p>119021, Москва, ул. Россолимо, 11А</p></bio><bio xml:lang="en"><p>Cand. Sci. (Med.), Senior Researcher at the Department of Innovative Vitreoretinal Technologies, Associate Professor at the Academic Department of Ophthalmology</p><p>11A Rossolimo St., Moscow, 119021</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-5507-8775</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Будзинская</surname><given-names>М. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Budzinskaya</surname><given-names>M. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>д.м.н., главный научный сотрудник отдела патологии сетчатки и зрительного нерва, профессор кафедры офтальмологии</p><p>119021, Москва, ул. Россолимо, 11А</p></bio><bio xml:lang="en"><p>Dr. Sci. (Med.), Chief Researcher at the Department of Retinal and Optic Nerve Pathology, Professor at the Academic Department of Ophthalmology</p><p>11A Rossolimo St., Moscow, 119021</p></bio><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГБНУ «НИИГБ им. М.М. Краснова»</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Krasnov Research Institute of Eye Diseases</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2024</year></pub-date><pub-date pub-type="epub"><day>12</day><month>12</month><year>2024</year></pub-date><volume>23</volume><issue>4</issue><fpage>11</fpage><lpage>20</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Андреева Ю.С., Алхарки Л., Будзинская М.В., 2024</copyright-statement><copyright-year>2024</copyright-year><copyright-holder xml:lang="ru">Андреева Ю.С., Алхарки Л., Будзинская М.В.</copyright-holder><copyright-holder xml:lang="en">Andreeva Y.S., Alharki L., Budzinskaya M.V.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.glaucomajournal.ru/jour/article/view/539">https://www.glaucomajournal.ru/jour/article/view/539</self-uri><abstract><sec><title>ЦЕЛЬ</title><p>ЦЕЛЬ. Сравнить морфометрические изменения параметров диска зрительного нерва (ДЗН) на фоне интравитреальных инъекций (ИВИ) афлиберцепта у пациентов с собственным и искусственным хрусталиком.</p></sec><sec><title>МЕТОДЫ</title><p>МЕТОДЫ. В исследование было включено 60 пациентов, которые были разделены на 2 группы: контрольная — 30 пациентов с собственным хрусталиком, основная — 30 пациентов с интраокулярной линзой. Всем пациентам трижды выполняли ИВВ афлиберцепта с интервалом в 4 недели, затем в течение года продолжали лечение в режиме «treat and extend». ВГД измеряли тонометром iCare Pro до ИВИ, через 1 минуту и 60 минут после ИВИ. Всем пациентам проводили оптическую когерентную томографию ДЗН, используя звездообразное сканирование. Анализировали горизонтальный срез ДЗН.</p></sec><sec><title>РЕЗУЛЬТАТЫ</title><p>РЕЗУЛЬТАТЫ. К концу срока наблюдения в обеих группах пациенты получили сравнимое количество ИВИ. Среднее повышение ВГД через 1 мин после ИВИ по сравнению с исходным превышало 15 мм рт.ст. в обеих группах. У пациентов контрольной группы спустя год лечения отмечалось увеличение ширины экскавации, медиана данного показателя увеличилась на 15 мкм (p&lt;0,001). Медиана глубины экскавации увеличилась на 8 мкм (p&lt;0,001). У пациентов основной группы также увеличилась ширина экскавации, медиана увеличилась на 6 мкм (p&lt;0,001), глубина экскавации увеличилась на 4 мкм (p&lt;0,001). В группе контроля данные изменения были статистически более выраженные, чем у пациентов основной группы. В обеих группах ширина отверстия мембраны Бруха и расстояние до передней поверхности решетчатой пластинки достоверно не изменились на протяжении всего периода наблюдения.</p></sec><sec><title>ЗАКЛЮЧЕНИЕ</title><p>ЗАКЛЮЧЕНИЕ. Ряд острых повышений ВГД вследствие многократных ИВИ в течение года ассоциируется с расширением ширины и глубины экскавации ДЗН, более выраженных при нативном хрусталике.</p></sec></abstract><trans-abstract xml:lang="en"><sec><title>PURPOSE</title><p>PURPOSE. To compare the changes in morphometric parameters of the optic nerve head (ONH) following intravitreal injections (IVI) of aflibercept in patients with natural and artificial lenses.</p></sec><sec><title>METHODS</title><p>METHODS. The study included 60 patients, divided into two groups: the control group, consisting of 30 patients with natural lenses, and the main group, consisting of 30 patients with intraocular lenses. All patients underwent three aflibercept IVIs at 4-week intervals, followed by a treat-and-extend regimen for one year. Intraocular pressure (IOP) was measured with the iCare Pro tonometer before IVI, and 1 minute and 60 minutes after IVI. All patients underwent optical coherence tomography (OCT) of the ONH, using radial (star-shaped) scans. Horizontal slices of the ONH were analyzed.</p></sec><sec><title>RESULTS</title><p>RESULTS. By the end of the observation period, both groups had received a comparable number of IVIs. The average IOP increase 1 minute after IVI exceeded 15 mm Hg compared to baseline in both groups. In the control group, one year after treatment, an increase in optic disc cup width was observed, with the median increasing by 15 μm (p&lt;0.001). The median cup depth increased by 8 μm (p&lt;0.001). In the main group, cup width also increased, with a median increase of 6 μm (p&lt;0.001), and cup depth increased by 4 μm (p&lt;0.001). These changes were statistically more pronounced in the control group compared to the main group. In both groups, the Bruch’s membrane opening diameter and the distance to the anterior surface of the lamina cribrosa did not significantly change throughout the observation period.</p></sec><sec><title>CONCLUSION</title><p>CONCLUSION. A series of acute IOP elevations due to repeated IVIs over the course of a year is associated with an increase in the width and depth of optic disc cup, which is more pronounced in patients with natural lenses.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>внутриглазное давление</kwd><kwd>афлиберцепт</kwd><kwd>оптическая когерентная томография</kwd><kwd>возрастная макулярная дегенерация</kwd><kwd>диск зрительного нерва.</kwd></kwd-group><kwd-group xml:lang="en"><kwd>intraocular pressure</kwd><kwd>aflibercept</kwd><kwd>optical coherence tomography</kwd><kwd>age-related macular degeneration</kwd><kwd>optic nerve head</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">CATT Research Group, Martin DF, Maguire MG, Ying GS, Grunwald JE, Fine SL, et al. Ranibizumab and bevacizumab for neovascular agerelated macular degeneration. N Engl J Med 2011; 364:1897-908. https://doi.org/10.1056/NEJMoa1102673</mixed-citation><mixed-citation xml:lang="en">CATT Research Group, Martin DF, Maguire MG, Ying GS, Grunwald JE, Fine SL, et al. Ranibizumab and bevacizumab for neovascular agerelated macular degeneration. N Engl J Med 2011; 364:1897-908. https://doi.org/10.1056/NEJMoa1102673</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Петрачков Д.В., Будзинская М.В., Павлов В.Г., Дуржинская М.Х., Халатян А.С. Нейродегенеративные биомаркеры ответа на терапию диабетического макулярного отека. Вестник офтальмологии 2020; 136(4):201206. https://doi.org/10.17116/oftalma2020136042201</mixed-citation><mixed-citation xml:lang="en">Petrachkov DV, Budzinskaya MV, Pavlov VG, Durzhinskaya MH, Khalatyan AS. Neurodegenerative biomarkers of the response to diabetic macular edema treatment. Russian Annals of Ophthalmology 2020; 136(4):201206. https://doi.org/10.17116/oftalma2020136042201</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Будзинская М.В., Плюхова А.А., Афанасьева М.А., Горкавенко Ф.В. Новые критерии эффективности анти-VEGF-терапии при экссудативной форме возрастной макулярной дегенерации. Вестник офтальмологии 2022; 138(4):58-66. https://doi.org/10.17116/oftalma202213804158</mixed-citation><mixed-citation xml:lang="en">Budzinskaya MV, Plyukhova AA, Afanasyeva MA, Gorkavenko FV. New criteria of effectiveness of anti-VEGF therapy in exudative agerelated macular degeneration. Russian Annals of Ophthalmology 2022; 138(4):58-66. https://doi.org/10.17116/oftalma202213804158</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Файзрахманов Р.Р. Анти-VEGF-терапия неоваскулярной возрастной макулярной дегенерации: от рандомизированных исследований — к реальной клинической практике. Российский офтальмологический журнал 2019; 12(2):97-105. https://doi.org/10.21516/2072-0076-2019-12-2-97-105</mixed-citation><mixed-citation xml:lang="en">Fayzrakhmanov R.R. Anti-VEGF therapy of neovascular age-related macular degeneration: from randomized trials to routine clinical practice. Russian Ophthalmological Journal 2019; 12(2):97-105. https://doi.org/10.21516/2072-0076-2019-12-2-97-105</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Wykoff C.C., Ou W.C., Brown D.M., et al. Randomized trial of treatand-extend versus monthly dosing for neovascular age-related macular degeneration: 2-year results of the TREX-AMD study. Ophthalmol Retina 2017; 1(4):314-321. https://doi.org/10.1016/j.oret.2016.12.004</mixed-citation><mixed-citation xml:lang="en">Wykoff C.C., Ou W.C., Brown D.M., et al. Randomized trial of treatand-extend versus monthly dosing for neovascular age-related macular degeneration: 2-year results of the TREX-AMD study. Ophthalmol Retina 2017; 1(4):314-321. https://doi.org/10.1016/j.oret.2016.12.004</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Kim JE, Mantravadi AV, Hur EY, Covert DJ. Short-term intraocular pressure changes immediately after intravitreal injections of antivascular endothelial growth factor agents. Am J Ophthalmol 2008; 146:930-934.e931. https://doi.org/10.1016/j.ajo.2008.07.007</mixed-citation><mixed-citation xml:lang="en">Kim JE, Mantravadi AV, Hur EY, Covert DJ. Short-term intraocular pressure changes immediately after intravitreal injections of antivascular endothelial growth factor agents. Am J Ophthalmol 2008; 146:930-934.e931. https://doi.org/10.1016/j.ajo.2008.07.007</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Eadie BD, Etminan M, Carleton BC, et al. Association of repeated intravitreous bevacizumab injections with risk for glaucoma surgery. JAMA Ophthalmol 2017; 135:363-368. https://doi.org/10.1001/jamaophthalmol.2017.0059.</mixed-citation><mixed-citation xml:lang="en">Eadie BD, Etminan M, Carleton BC, et al. Association of repeated intravitreous bevacizumab injections with risk for glaucoma surgery. JAMA Ophthalmol 2017; 135:363-368. https://doi.org/10.1001/jamaophthalmol.2017.0059.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Бубнова И.А., Юлова А.Г. Изменение морфометрических параметров ДЗН на фоне острого повышения ВГД после интравитреальных инъекций. Национальный журнал глаукома 2016; 15(2):54-60.</mixed-citation><mixed-citation xml:lang="en">Bubnova I., Yulova A. Optic nerve head changes with acute IOP elevation after intravitreal injections. National journal glaucoma 2016; 15(2):54-60.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Jiang, R., Xu, L., Liu, X., Chen, J. D., Jonas, J. B., &amp; Wang, Y. X. Optic Nerve Head Changes after Short-Term Intraocular Pressure Elevation in Acute Primary Angle-Closure Suspects. Ophthalmology 2015; 122(4):730-737. https://doi.org/10.1016/j.ophtha.2014.11.008</mixed-citation><mixed-citation xml:lang="en">Jiang, R., Xu, L., Liu, X., Chen, J. D., Jonas, J. B., &amp; Wang, Y. X. Optic Nerve Head Changes after Short-Term Intraocular Pressure Elevation in Acute Primary Angle-Closure Suspects. Ophthalmology 2015; 122(4):730-737. https://doi.org/10.1016/j.ophtha.2014.11.008</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Страхов В.В., Корчагин Н.В., Попова А.А. Биомеханический аспект формирования глаукомной экскавации. Национальный журнал глаукома 2015; 14(3):58-71.</mixed-citation><mixed-citation xml:lang="en">Strakhov V.V., Korchagin N.V., Popova A.A. The biomechanical aspect of the pathological optic disc cupping development in glaucoma. National journal glaucoma 2015; 14(3):58-71.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Alaghband P, Beltran-Agulló L, Galvis E, Overby D, Lim K. Effect of phacoemulsification on facility of outflow. British Journal of Ophthalmology 2018; 102(11):1520-1526. https://doi.org/10.1136/bjophthalmol-2017-311548</mixed-citation><mixed-citation xml:lang="en">Alaghband P, Beltran-Agulló L, Galvis E, Overby D, Lim K. Effect of phacoemulsification on facility of outflow. British Journal of Ophthalmology 2018; 102(11):1520-1526. https://doi.org/10.1136/bjophthalmol-2017-311548</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Nolan P.; See L.; Friedman, David S.; Chan, Yiong-Huak. Changes in Angle Configuration After Phacoemulsification Measured by Anterior Segment Optical Coherence Tomography. Journal of Glaucoma 2008; 17(6):455-459. https://doi.org/10.1097/IJG.0b013e3181650f31</mixed-citation><mixed-citation xml:lang="en">Nolan P.; See L.; Friedman, David S.; Chan, Yiong-Huak. Changes in Angle Configuration After Phacoemulsification Measured by Anterior Segment Optical Coherence Tomography. Journal of Glaucoma 2008; 17(6):455-459. https://doi.org/10.1097/IJG.0b013e3181650f31</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Kerimoglu, H., Ozturk, B. T., Bozkurt, B., Okka, M., &amp; Okudan, S. Does lens status affect the course of early intraocular pressure and anterior chamber changes after intravitreal injection? Acta Ophthalmologica 2011; 89(2):138-142. https://doi.org/10.1111/j.1755-3768.2009.01656.x</mixed-citation><mixed-citation xml:lang="en">Kerimoglu, H., Ozturk, B. T., Bozkurt, B., Okka, M., &amp; Okudan, S. Does lens status affect the course of early intraocular pressure and anterior chamber changes after intravitreal injection? Acta Ophthalmologica 2011; 89(2):138-142. https://doi.org/10.1111/j.1755-3768.2009.01656.x</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Atchison E, Wood K, Mattox C, Barry C, Lum F, MacCumber M. The real-world effect of intravitreous anti–vascular endothelial growth factor drugs on intraocular pressure: an analysis using the IRIS registry. Ophthalmology 2018; 125:676-682. https://doi.org/10.1016/j.ophtha.2017.11.027</mixed-citation><mixed-citation xml:lang="en">Atchison E, Wood K, Mattox C, Barry C, Lum F, MacCumber M. The real-world effect of intravitreous anti–vascular endothelial growth factor drugs on intraocular pressure: an analysis using the IRIS registry. Ophthalmology 2018; 125:676-682. https://doi.org/10.1016/j.ophtha.2017.11.027</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">El Chehab H, Agard E, Russo A, Boujnah Y, Dot C. Intraocular Pressure Spikes after Aflibercept Intravitreal Injections. Ophthalmologica 2016; 236:43-47. https://doi.org/10.1159/000446878</mixed-citation><mixed-citation xml:lang="en">El Chehab H, Agard E, Russo A, Boujnah Y, Dot C. Intraocular Pressure Spikes after Aflibercept Intravitreal Injections. Ophthalmologica 2016; 236:43-47. https://doi.org/10.1159/000446878</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Бубнова И. А., Кургузова А. Г. Изменения уровня ВГД после интравитреальных инъекций. Вестник офтальмологии 2018; 134(4):47-51. https://doi.org/10.17116/oftalma201813404147</mixed-citation><mixed-citation xml:lang="en">Bubnova I A, Kurguzova A G. Changes in intraocular pressure after intravitreal injections. Russian Annals of Ophthalmology 2018; 134(4): 47-51. https://doi.org/10.17116/oftalma201813404147</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Singh, K., Cheema, A., Kung, J., &amp; Choi, D. Cataract surgery in the glaucoma patient. Middle East African Journal of Ophthalmology 2015; 22(1):10-17. https://doi.org/10.4103/0974-9233.148343</mixed-citation><mixed-citation xml:lang="en">Singh, K., Cheema, A., Kung, J., &amp; Choi, D. Cataract surgery in the glaucoma patient. Middle East African Journal of Ophthalmology 2015; 22(1):10-17. https://doi.org/10.4103/0974-9233.148343</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Poley B.J., Lindstrom R.L. Longterm effects of phacoemulsification with intraocular lens implantation in normotensive and ocular hypertensive eyes. J Cataract Refract Surg 2008; 34(5):735-742. https://doi.org/10.1016/j.jcrs.2007.12.045</mixed-citation><mixed-citation xml:lang="en">Poley B.J., Lindstrom R.L. Longterm effects of phacoemulsification with intraocular lens implantation in normotensive and ocular hypertensive eyes. J Cataract Refract Surg 2008; 34(5):735-742. https://doi.org/10.1016/j.jcrs.2007.12.045</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Burgoyne C.F., Downs J.C., Bellezza A.J. at al. The optic nerve head as biomechanical structure: a new paradigm for understanding the role of IOP-related stress and strain in the pathophysiology of glaucomatous optic nerve head damage. Prog Retin Eye Res 2005; 24(1):19-73. https://doi.org/10.1016/j.preteyeres.2004.06.001</mixed-citation><mixed-citation xml:lang="en">Burgoyne C.F., Downs J.C., Bellezza A.J. at al. The optic nerve head as biomechanical structure: a new paradigm for understanding the role of IOP-related stress and strain in the pathophysiology of glaucomatous optic nerve head damage. Prog Retin Eye Res 2005; 24(1):19-73. https://doi.org/10.1016/j.preteyeres.2004.06.001</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
